Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Gerald Verhaegh"'
Autor:
Uta Erdbrügger, Charles J. Blijdorp, Irene V. Bijnsdorp, Francesc E. Borràs, Dylan Burger, Benedetta Bussolati, James Brian Byrd, Aled Clayton, James W. Dear, Juan M. Falcón‐Pérez, Cristina Grange, Andrew F. Hill, Harry Holthöfer, Ewout J. Hoorn, Guido Jenster, Connie R. Jimenez, Kerstin Junker, John Klein, Mark A. Knepper, Erik H. Koritzinsky, James M. Luther, Metka Lenassi, Janne Leivo, Inge Mertens, Luca Musante, Eline Oeyen, Maija Puhka, Martin E. vanRoyen, Catherine Sánchez, Carolina Soekmadji, Visith Thongboonkerd, Volkert vanSteijn, Gerald Verhaegh, Jason P. Webber, Kenneth Witwer, Peter S.T. Yuen, Lei Zheng, Alicia Llorente, Elena S. Martens‐Uzunova
Publikováno v:
Journal of Extracellular Vesicles, Vol 10, Iss 7, Pp n/a-n/a (2021)
Abstract Urine is commonly used for clinical diagnosis and biomedical research. The discovery of extracellular vesicles (EV) in urine opened a new fast‐growing scientific field. In the last decade urinary extracellular vesicles (uEVs) were shown to
Externí odkaz:
https://doaj.org/article/11056fe3164342fca660fd4db4496dcd
Autor:
Olli Kallioniemi, Matthias Nees, Jack Schalken, Gerald Verhaegh, Frank Smit, Mari Peltola, Rolf I. Skotheim, Sami Kilpinen, Santosh Gupta, Henrik Edgren, Maija Wolf, Kristiina Iljin
Supplementary Figure S3 from TMPRSS2 Fusions with Oncogenic ETS Factors in Prostate Cancer Involve Unbalanced Genomic Rearrangements and Are Associated with HDAC1 and Epigenetic Reprogramming
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0a58b9d9a93bcdd921681dd4235940f
https://doi.org/10.1158/0008-5472.22366617.v1
https://doi.org/10.1158/0008-5472.22366617.v1
Autor:
Olli Kallioniemi, Matthias Nees, Jack Schalken, Gerald Verhaegh, Frank Smit, Mari Peltola, Rolf I. Skotheim, Sami Kilpinen, Santosh Gupta, Henrik Edgren, Maija Wolf, Kristiina Iljin
Supplementary Table S4-S6 from TMPRSS2 Fusions with Oncogenic ETS Factors in Prostate Cancer Involve Unbalanced Genomic Rearrangements and Are Associated with HDAC1 and Epigenetic Reprogramming
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01164293037a4d6af7f7cbb0c618c1d9
https://doi.org/10.1158/0008-5472.22366605
https://doi.org/10.1158/0008-5472.22366605
Autor:
Olli Kallioniemi, Matthias Nees, Jack Schalken, Gerald Verhaegh, Frank Smit, Mari Peltola, Rolf I. Skotheim, Sami Kilpinen, Santosh Gupta, Henrik Edgren, Maija Wolf, Kristiina Iljin
Supplementary Table S1 from TMPRSS2 Fusions with Oncogenic ETS Factors in Prostate Cancer Involve Unbalanced Genomic Rearrangements and Are Associated with HDAC1 and Epigenetic Reprogramming
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a4ecadfb11ef1782d381a66f80c1bc1
https://doi.org/10.1158/0008-5472.22366614
https://doi.org/10.1158/0008-5472.22366614
Autor:
Olli Kallioniemi, Matthias Nees, Jack Schalken, Gerald Verhaegh, Frank Smit, Mari Peltola, Rolf I. Skotheim, Sami Kilpinen, Santosh Gupta, Henrik Edgren, Maija Wolf, Kristiina Iljin
Translocations fusing the strong androgen-responsive gene, TMPRSS2, with ERG or other oncogenic ETS factors may facilitate prostate cancer development. Here, we studied 18 advanced prostate cancers for ETS factor alterations, using reverse transcript
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b14a9d2047032f3ca68a4802b02f454
https://doi.org/10.1158/0008-5472.c.6495216.v1
https://doi.org/10.1158/0008-5472.c.6495216.v1
Publikováno v:
Prostate International, Vol 2, Iss 3, Pp 105-113 (2014)
Development of castration-resistant prostate cancer (CRPC) in a low androgen environment, arising from androgen deprivation therapy (ADT), is a major problem in patients with advanced prostate cancer (PCa). Several mechanisms have been hypothesized t
Externí odkaz:
https://doaj.org/article/b04129069fdd4684b78810c4583e95fe
Autor:
Gerald Verhaegh, Diederik M. Somford, Tineke J. Smilde, Frank Smit, Levi Groen, Nielka P. van Erp, Onno van Hooij, Emmy Boerrigter, Inge M. van Oort, Pieter de Mol, Irma M. Oving, Guillemette E. Benoist, Niven Mehra, Jack A. Schalken
Publikováno v:
Cancer Research. 80:1413-1413
Background Abiraterone acetate is registered for treatment of metastatic prostate cancer, including those with castration-resistant disease (mCRPC). Although it improves overall survival and progression free survival (PFS), treatment response differs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4bb1b100f508076bd354737d7ccb15a
https://doi.org/10.1158/1538-7445.am2020-1413
https://doi.org/10.1158/1538-7445.am2020-1413
Autor:
Cornelius F.J. Jansen, M. De Weijert, M. Janicot, I. Schultz, O. Van Hooij, K. Nikolakopoulou, Roel Q.J. Schaapveld, J.G.M. Van Kampen, J.A. Schalken, Frank Smit, Gerald Verhaegh
Publikováno v:
European Urology Supplements. 17:e2489
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26cbc82f273efb170f4e787418f1d0c1
https://doi.org/10.1016/s1569-9056(18)32974-9
https://doi.org/10.1016/s1569-9056(18)32974-9
Autor:
M. Janicot, J.A. Schalken, Gerald Verhaegh, M. De Weijert, I. Schultz, J.G.M. Van Kampen, Roel Q.J. Schaapveld, K. Nikolakopoulou, Frank Smit
Publikováno v:
European Urology Supplements. 17:e2547
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e873059820b6d947331e1439db02feb1
https://doi.org/10.1016/s1569-9056(18)33026-4
https://doi.org/10.1016/s1569-9056(18)33026-4
Publikováno v:
European Urology Supplements. 17:e2537
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e82d46d4c2348bd5425d60b647b39fa6
https://doi.org/10.1016/s1569-9056(18)33017-3
https://doi.org/10.1016/s1569-9056(18)33017-3